Copyright Reports & Markets. All rights reserved.

Global Phage Therapy Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Phage Therapy Kits Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Medical Grade
    • 1.3.3 Laboratory Grade
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Phage Therapy Kits Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Medical
    • 1.4.3 Food Industry
    • 1.4.4 Agriculture
    • 1.4.5 Others
  • 1.5 Global Phage Therapy Kits Market Size & Forecast
    • 1.5.1 Global Phage Therapy Kits Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Phage Therapy Kits Sales Quantity (2020-2031)
    • 1.5.3 Global Phage Therapy Kits Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 BiomX
    • 2.1.1 BiomX Details
    • 2.1.2 BiomX Major Business
    • 2.1.3 BiomX Phage Therapy Kits Product and Services
    • 2.1.4 BiomX Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 BiomX Recent Developments/Updates
  • 2.2 PhagePro
    • 2.2.1 PhagePro Details
    • 2.2.2 PhagePro Major Business
    • 2.2.3 PhagePro Phage Therapy Kits Product and Services
    • 2.2.4 PhagePro Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 PhagePro Recent Developments/Updates
  • 2.3 PhagoMed Biopharma
    • 2.3.1 PhagoMed Biopharma Details
    • 2.3.2 PhagoMed Biopharma Major Business
    • 2.3.3 PhagoMed Biopharma Phage Therapy Kits Product and Services
    • 2.3.4 PhagoMed Biopharma Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 PhagoMed Biopharma Recent Developments/Updates
  • 2.4 MYRIADE
    • 2.4.1 MYRIADE Details
    • 2.4.2 MYRIADE Major Business
    • 2.4.3 MYRIADE Phage Therapy Kits Product and Services
    • 2.4.4 MYRIADE Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 MYRIADE Recent Developments/Updates
  • 2.5 DotBio
    • 2.5.1 DotBio Details
    • 2.5.2 DotBio Major Business
    • 2.5.3 DotBio Phage Therapy Kits Product and Services
    • 2.5.4 DotBio Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 DotBio Recent Developments/Updates
  • 2.6 Wuhan Greinon Biotechnology
    • 2.6.1 Wuhan Greinon Biotechnology Details
    • 2.6.2 Wuhan Greinon Biotechnology Major Business
    • 2.6.3 Wuhan Greinon Biotechnology Phage Therapy Kits Product and Services
    • 2.6.4 Wuhan Greinon Biotechnology Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Wuhan Greinon Biotechnology Recent Developments/Updates
  • 2.7 PhagePharm
    • 2.7.1 PhagePharm Details
    • 2.7.2 PhagePharm Major Business
    • 2.7.3 PhagePharm Phage Therapy Kits Product and Services
    • 2.7.4 PhagePharm Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 PhagePharm Recent Developments/Updates
  • 2.8 iNtRON Biotechnology
    • 2.8.1 iNtRON Biotechnology Details
    • 2.8.2 iNtRON Biotechnology Major Business
    • 2.8.3 iNtRON Biotechnology Phage Therapy Kits Product and Services
    • 2.8.4 iNtRON Biotechnology Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 iNtRON Biotechnology Recent Developments/Updates
  • 2.9 Snipr Technologies
    • 2.9.1 Snipr Technologies Details
    • 2.9.2 Snipr Technologies Major Business
    • 2.9.3 Snipr Technologies Phage Therapy Kits Product and Services
    • 2.9.4 Snipr Technologies Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Snipr Technologies Recent Developments/Updates
  • 2.10 CJ
    • 2.10.1 CJ Details
    • 2.10.2 CJ Major Business
    • 2.10.3 CJ Phage Therapy Kits Product and Services
    • 2.10.4 CJ Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 CJ Recent Developments/Updates
  • 2.11 Phico Therapeutics
    • 2.11.1 Phico Therapeutics Details
    • 2.11.2 Phico Therapeutics Major Business
    • 2.11.3 Phico Therapeutics Phage Therapy Kits Product and Services
    • 2.11.4 Phico Therapeutics Phage Therapy Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Phico Therapeutics Recent Developments/Updates

3 Competitive Environment: Phage Therapy Kits by Manufacturer

  • 3.1 Global Phage Therapy Kits Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Phage Therapy Kits Revenue by Manufacturer (2020-2025)
  • 3.3 Global Phage Therapy Kits Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Phage Therapy Kits by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Phage Therapy Kits Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Phage Therapy Kits Manufacturer Market Share in 2024
  • 3.5 Phage Therapy Kits Market: Overall Company Footprint Analysis
    • 3.5.1 Phage Therapy Kits Market: Region Footprint
    • 3.5.2 Phage Therapy Kits Market: Company Product Type Footprint
    • 3.5.3 Phage Therapy Kits Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Phage Therapy Kits Market Size by Region
    • 4.1.1 Global Phage Therapy Kits Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Phage Therapy Kits Consumption Value by Region (2020-2031)
    • 4.1.3 Global Phage Therapy Kits Average Price by Region (2020-2031)
  • 4.2 North America Phage Therapy Kits Consumption Value (2020-2031)
  • 4.3 Europe Phage Therapy Kits Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Phage Therapy Kits Consumption Value (2020-2031)
  • 4.5 South America Phage Therapy Kits Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Phage Therapy Kits Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Phage Therapy Kits Sales Quantity by Type (2020-2031)
  • 5.2 Global Phage Therapy Kits Consumption Value by Type (2020-2031)
  • 5.3 Global Phage Therapy Kits Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Phage Therapy Kits Sales Quantity by Application (2020-2031)
  • 6.2 Global Phage Therapy Kits Consumption Value by Application (2020-2031)
  • 6.3 Global Phage Therapy Kits Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Phage Therapy Kits Sales Quantity by Type (2020-2031)
  • 7.2 North America Phage Therapy Kits Sales Quantity by Application (2020-2031)
  • 7.3 North America Phage Therapy Kits Market Size by Country
    • 7.3.1 North America Phage Therapy Kits Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Phage Therapy Kits Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Phage Therapy Kits Sales Quantity by Type (2020-2031)
  • 8.2 Europe Phage Therapy Kits Sales Quantity by Application (2020-2031)
  • 8.3 Europe Phage Therapy Kits Market Size by Country
    • 8.3.1 Europe Phage Therapy Kits Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Phage Therapy Kits Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Phage Therapy Kits Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Phage Therapy Kits Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Phage Therapy Kits Market Size by Region
    • 9.3.1 Asia-Pacific Phage Therapy Kits Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Phage Therapy Kits Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Phage Therapy Kits Sales Quantity by Type (2020-2031)
  • 10.2 South America Phage Therapy Kits Sales Quantity by Application (2020-2031)
  • 10.3 South America Phage Therapy Kits Market Size by Country
    • 10.3.1 South America Phage Therapy Kits Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Phage Therapy Kits Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Phage Therapy Kits Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Phage Therapy Kits Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Phage Therapy Kits Market Size by Country
    • 11.3.1 Middle East & Africa Phage Therapy Kits Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Phage Therapy Kits Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Phage Therapy Kits Market Drivers
  • 12.2 Phage Therapy Kits Market Restraints
  • 12.3 Phage Therapy Kits Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Phage Therapy Kits and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Phage Therapy Kits
  • 13.3 Phage Therapy Kits Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Phage Therapy Kits Typical Distributors
  • 14.3 Phage Therapy Kits Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Phage Therapy Kits market size was valued at US$ 43.1 million in 2024 and is forecast to a readjusted size of USD 115 million by 2031 with a CAGR of 15.2% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.
    Phage therapy, the therapeutic use of bacteriophages (viruses that infect bacteria), is a promising field with significant potential to address the growing challenge of antibiotic resistance. As such, the market for phage therapy kits is expected to experience substantial growth in the coming years.
    Here are some key trends that are likely to shape the future market for phage therapy kits:
    1. Increasing Prevalence of Antibiotic Resistance:
    Rising antibiotic resistance: The overuse and misuse of antibiotics have led to a global increase in antibiotic-resistant bacteria, making traditional treatments less effective. This will drive demand for alternative solutions like phage therapy.
    Expanded applications: Phage therapy is being explored for a wide range of infections, including skin infections, urinary tract infections, and respiratory infections. As research progresses and clinical trials demonstrate efficacy, the market for phage therapy kits will expand.
    2. Advancements in Phage Research and Development:
    Improved phage identification and characterization: Technological advancements will enable faster and more accurate identification and characterization of phages, leading to the development of more targeted and effective phage therapy kits.
    Enhanced phage engineering: Researchers are exploring ways to engineer phages to improve their therapeutic properties, such as increasing their stability, broadening their host range, and enhancing their ability to overcome bacterial defenses.
    3. Growing Regulatory Acceptance:
    Regulatory approvals: As regulatory bodies gain more experience with phage therapy, we can expect to see an increase in approvals for phage therapy products. This will provide greater market access and boost investor confidence.
    International collaboration: Global cooperation and harmonization of regulatory frameworks will facilitate the development and commercialization of phage therapy kits across different regions.
    4. Increased Investment and Industry Interest:
    Venture capital and pharmaceutical investments: The potential of phage therapy to address the antibiotic resistance crisis has attracted significant investment from venture capital firms and pharmaceutical companies. This increased interest will drive innovation and accelerate the development of phage therapy kits.
    Partnerships and collaborations: Strategic partnerships between academic institutions, research organizations, and biotechnology companies will foster collaboration and accelerate the translation of phage therapy research into commercial products.
    5. Personalized Phage Therapy:
    Tailored phage cocktails: Advancements in genomics and personalized medicine will enable the development of customized phage cocktails that are specifically tailored to individual patients and their unique infections.
    Precision phage therapy: This approach will improve treatment outcomes and reduce the risk of adverse effects.
    Overall, the future market for phage therapy kits is poised for significant growth driven by the increasing prevalence of antibiotic resistance, advancements in phage research, regulatory acceptance, increased investment, and the potential for personalized phage therapy. As the field continues to evolve, we can expect to see a wider range of phage therapy products becoming available to patients, offering new hope for the treatment of antibiotic-resistant infections.
    This report is a detailed and comprehensive analysis for global Phage Therapy Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Phage Therapy Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Phage Therapy Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Phage Therapy Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Phage Therapy Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Phage Therapy Kits
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Phage Therapy Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BiomX, PhagePro, PhagoMed Biopharma, MYRIADE, DotBio, Wuhan Greinon Biotechnology, PhagePharm, iNtRON Biotechnology, Snipr Technologies, CJ, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Phage Therapy Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Medical Grade
    Laboratory Grade
    Market segment by Application
    Medical
    Food Industry
    Agriculture
    Others
    Major players covered
    BiomX
    PhagePro
    PhagoMed Biopharma
    MYRIADE
    DotBio
    Wuhan Greinon Biotechnology
    PhagePharm
    iNtRON Biotechnology
    Snipr Technologies
    CJ
    Phico Therapeutics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Phage Therapy Kits product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Phage Therapy Kits, with price, sales quantity, revenue, and global market share of Phage Therapy Kits from 2020 to 2025.
    Chapter 3, the Phage Therapy Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Phage Therapy Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Phage Therapy Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Phage Therapy Kits.
    Chapter 14 and 15, to describe Phage Therapy Kits sales channel, distributors, customers, research findings and conclusion.

    Buy now